ABSTRACT
INTRODUCTION
Ribozymes are catalytic RNA molecules with endoribonuclease activity (4, 12, 24) . The hammerhead type, because of its simplicity, is one of the best studied and most commonly used. It contains two different domains: an antisense region, represented by helix I and helix III, responsible for the recognition and binding to the target RNA, and a catalytic domain, helix II, which causes the cleavage of the RNA. Modification of the antisense domain allows redirection of the specificity of the molecule without affecting its catalytic properties (14) . This makes it theoretically possible to down-regulate the amount of any given messenger RNA inside cells, as long as the target sequence is known and contains potential ribozyme cleavage sites.
Although ribozymes share potential applications with antisense oligonucleotides, they have the advantage of catalytic activity that theoretically can allow a single molecule to destroy more than one target RNA. Nevertheless, accumulated experience indicates that usually a large molar excess of ribozyme over substrate is needed to obtain a significant reduction in the level of messenger RNA (3, 8, 9) . A major factor accounting for this observation is the development of secondary structures by the target RNA and ribozyme that interfere with the necessary hybridization step (11, 27) . Furthermore, cleavage studies to assess activity of ribozymes are often based on synthetic substrate and ribozyme transcripts that are usually shorter than can be produced by expression vectors in vivo. Cloning strategies require the introduction of restriction sites into expression vectors and contribute additional sequences upstream and downstream from the ribozyme target sequence. Nonproductive folding and nonspecific hybridization of the ribozyme due to these extra sequences likely account for a portion of the loss of activity observed in vivo (1, 10, 11, 23) .
In this paper, we describe a system for making tandem repeats of a single self-cleavable hammerhead molecule that act simultaneously as a cisand trans ribozyme. This design has the advantage of exploiting the versatility of expression vectors to synthesize the ribozyme inside the cells, with the release of large numbers of molecules comparable in size with those produced by chemical synthesis. We describe the self-cleavage kinetics of this molecule as well as its trans -cleavage activity of an RNA target molecule.
MATERIALS AND METHODS

Construction of Ribozyme Tandems and Expression Vectors
Two 78-nucleotide (nt)-long oligodeoxynucleotides encoding a hammerhead ribozyme directed against the core region of the hepatitis B virus (HBV), nucleotides 2021-2045, and the elements necessary for further subcloning ( Figure 1 , A and B) were synthesized (Midland Certified Reagent, Midland, TX, USA), annealed and cloned into a Xba I-Hin dIII site in Bluescript ® SK(+) (Stratagene, La Jolla, CA, USA), to create pBMRz (GenBank ® Accession No. 43954). The target sequence recognized by the ribozyme was introduced downstream from the catalytic sequence to make the molecule self-cleavable.
The strategy used to prepare the tandem repeats of self-processing ribozymes was based on the use of restriction enzymes that produce compatible ends upon digestion. We have introduced into the basic cloning unit the recognition sites for Xba I and Spe I at each end of the molecule ( Figure 1A) . Fragments produced by digestion with one enzyme can be cloned into fragments produced by digestion with the other; however, after ligation those restriction sites are lost and no longer recognized by either enzyme. When a second digestion with both enzymes is performed, ends that the ligase has joined with the same restriction enzyme termini ( Xba I/ Xba I or Spe I/ Spe I) will be cut, but not those that contain different ends ( Xba I/ Spe I or Spe I/ Xba I). The fragments can then be separated and purified by agarose or polyacrylamide electrophoresis. A combination of successive ligation and digestion reactions can increase the length of the tandem and assure the directionality of the final product. According to this scheme, pBMRz was digested with Xba I-Spe I, and the 70-nt fragment containing the ribozyme was separated by agarose gel electrophoresis, recovered from the gel and allowed to self-ligate with T4 DNA ligase (Life Technologies, Gaithersburg, MD, USA). A second digestion with Xba ISpe I was performed, and the products were separated in a 1% agarose gel. A band containing four copies of the ribozyme was purified and ligated into Xba I-linearized pBMRz to create pB5T-MRz (GenBank Accession No. 43956). Sequencing was performed to confirm the orientation and nucleotide composition of the tandem. Following the same procedure, a second plasmid, pB10T-MRz (GenBank Accession No. 43957), containing 10 copies of the ribozyme was created. An expression vector containing a single copy of the ribozyme without the self-cleaving target sequence, pBRz (GenBank Accession No. 43955), was cloned by ligating a Xba I/ BamHI pBMRz fragment into Bluescript SK(+).
In Vitro Synthesis of Ribozymes and RNA Target
In vitro transcription of linearized plasmids was carried out as described by Milligan and Uhlenbeck (18) pBMRz was linearized with Kpn I; pB5T-MRz and pB10T-MRz were digested with Hin dIII to assay self-processing and trans -cleavage of tandems by kinetic means; finally, pBRz was linearized with BamHI or Pvu II to produce a monomeric ribozyme truncated or extended at the 3 ′ end of the selfcleaving target sequence, respectively. Figure 2 depicts the structures of the pentameric Ribozyme I, monomeric 3 ′ -truncated Ribozyme II and monomeric 3 ′ -extended Ribozyme III.
The HBV RNA substrate used for trans -ribozyme cleavage reactions was transcribed from a 1.2-Kb Ssp I fragment purified from adwR9, a plasmid containing two head-to-tail copies of the hepatitis B viral genome (obtained from Dr. T. Jake Liang, Massachusetts General Hospital, Boston, MA) (17) . The 858-nt-long T7 RNA polymerasesynthesized RNA includes nucleotides 1413-2256 of the HBV genome in the core gene of the pre -genomic RNA.
Both nonradioactive and 32 P-labeled UTP were used to decrease the amount of incomplete transcripts during the T3 and T7 RNA polymerase reactions. The nucleotide concentration in the transcription reaction mixture was increased to 8 mM to minimize the free Mg ++ concentration and reduce the self-processing activity during the transcription reaction.
Cis Self-Cleavage Reaction of Tandem Ribozyme
Tubes containing 2 pmol of Ribozyme I in 18 µ L 50 mM Tris-HCl, pH 7.5, were heated to 95°C for 3 min and cooled on ice. Cleavage was initiated by the addition of 2 µ L of 100 mM MgCl 2 . Samples were incubated at 37°C for 3 h, and aliquots were taken at different times. Reactions were stopped immediately by the addition of EDTA to a final concentration of 100 mM. The influence of the presence of target RNA in the self-processing reaction was assessed under the same conditions described before, except that 2 pmol of unlabeled HBV RNA were added before the denaturing step.
In Vitro Trans -Cleavage Ribozyme Reaction
Both target and ribozyme transcripts were mixed in varying ratios, and reactions were carried out under the same conditions described above except that there was no denaturing step. The effect of the number of released monomeric ribozyme molecules from Ribozyme I in thetrans -cleavage reaction was assessed by including a pre-incubation step (37°C for 3 h) before the addition of the target HBV RNA.
Cleavage products were resolved in denaturing 5% polyacrylamide-8 M urea gels, and the results were quantitatively analyzed with a PhosphorImager ™ (Molecular Dynamics, Sunnyvale, CA, USA). Cleavage percentages were calculated using the formula: P1+P2/S+P1+P2, where P1 and P2 are the cleavage products and S is the fulllength HBV RNA. All experiments were performed at least in duplicate and most were done in triplicate.
RESULTS
Construction of Plasmids Bearing Ribozyme Cassettes
The cloning procedures generated three constructs containing one, five and ten copies of self-cleaving ribozymes (pBMRz, pB5T-MRz and pB10T-MRz, respectively) and one construct containing a monomeric nonself-cleaving ribozyme (pBRz). Plasmid constructs were checked by restriction enzyme patterns and correct sequence, and direction of the plasmid containing Ribozyme I was determined by sequencing (data not shown). To assess the ability of the different constructs to self-cleave, RNAs were synthesized from each linearized plasmid under standard conditions, and the products were resolved in a polyacrylamide denaturing gel. Figure 3A shows that, even without a separate cleavage incubation step (lane 1), Ribozyme I transcripts cleaved themselves into various multimeric units because of the presence of MgCl 2 in the transcription buffer. For reference, expected cleavage products are shown in the diagram in Figure 3B . The efficiency of cleavage for monomeric units at time 0 (released during transcription) was calculated to be 17.7%. After 3 h incubation, the efficiency reached nearly 80% ( Figure 3A, 180 min) . The presence of the HBV RNA target in a 1:1 ratio did not influence the self-processing reaction at any time point (data not shown).
Trans -Cleavage Ribozyme Activity of Monomeric vs. Multimeric Transcripts
To compare the activity of monomeric non-self-processing ribozymes with multimeric transcripts, two pBRzderived RNAs varying in the length of best, half the number of molecules of Ribozyme II. Figure 5A summarizes the results of cleavage target RNA obtained under the different conditions tested. Ribozyme-to-target RNA molar ratios were selected to compare Ribozyme I with Ribozymes II and III by considering ( i ) the number of ribozyme transcript molecules and ( ii ) the total theoretical number of ribozyme units released from Ribozyme I. When compared based on equal molar ratios of total ribozyme units to target RNA molecules (0.2:1 ratio of Ribozyme I transcripts to target RNA vs. 1:1 ratio of Ribozymes II and III to target), Ribozyme I was three times more efficient than Ribozyme III and 50% more efficient than Ribozyme II after 3 h of incubation. Similar effects were seen at higher total ribozyme unit concentrations: 2:1 ratio of Ribozyme I transcripts to target RNA vs. 10:1 ratio of Ribozymes II and III to target, resulted in significantly greater efficiency, 35%, and 71%, respectively, after 3 h of incubation. As expected, progressively higher ratios of total selfcleavable ribozyme units to RNA target molecules resulted in progressively higher cleavage efficiencies.
Effect of Pre-incubation on TransCleavage Activity of Multimeric Ribozymes
Previous results of the comparison of trans -cleavage activities of monomeric trans -acting ribozymes vs. multimeric ribozymes were based on theoretical calculations of the number of ribozyme units that could be released from Ribozyme I after a fully completed self-cleavage reaction. However, self-processing kinetics shown in Figure 3A demonstrated that, although there was efficient and progressive liberation of monomeric units, the maximum extent of self-cleavage only reached 80% after 3 h of incubation. This means that the actual number of monomeric ribozyme molecules involved in the trans -cleavage reaction with incubation times shorter than 3 h in the previous experiments was, in fact, less than the maximum theoretically generated. To study the kinetics of digestion of target RNA starting with 80% monomeric ribozyme species, experiments were repeated under the same ratios of ribozyme to target, but Ribozyme I was pre-incubated for 3 h before the target was added. Results of these experiments are shown in Figure  5B . As expected, activities were increased, especially during the first 2 h of the trans -cleavage reaction. However, by the end of the incubation, cleavage values approached those obtained with non pre-incubated multimeric ribozymes.
DISCUSSION
The simplicity of the design and the specificity of the enzymatic activity make ribozymes, especially the hammerhead type, potentially valuable tools for research and clinical applications (2,7). However, technical difficulties remain to be solved before ribozymes reach widespread use. Ideally, ribozymes should co-localize with the target RNA in the same subcellular compartment, hybridize with its complementary region in the target RNA and turn over after cleavage of the target to accept a new target molecule. Because these ideal features are often not achieved (10, 16, 22) , large amounts of ribozyme molecules inside the cells are currently required to obtain a significant biologic effect. Chemically syn - thesized ribozymes have the advantage of being synthesized without extra sequences that can interfere with hybridization, and they can be modified to make them more resistant to RNases (20, 21, 28) . However, when prolonged activity is needed, such ribozymes would require repeated administration. Alternatively, the activity of the ribozymes synthesized inside the cells could be improved by multiplying the number of catalytic molecules generated per cell and/or by increasing the activity of the individual molecules. Several authors have previously described the use of expression vectors containing connected, non-independent hammerhead ribozymes making tandems of molecules with the same or different cleavage specificities (1, 5, 26) . However, after reaching a certain limit, the addition of more units to the construct did not result in an increase in the activity of the molecule (19) . Other investigators have used cis -acting ribozymes to minimize the extra sequences upstream and/or downstream from the trans -acting sequence (6, 15, 25, 29, 30) , resulting in an increase in the transcleavage activity compared with longer transcripts (6) . Finally, a combination of both ideas led to the design of a shotgun-type ribozyme expression vector consisting of plasmids that produce tandem-connected, trans -acting ribozymes that are made monomeric by the presence of a second (different) cisacting ribozyme (19) .
In our experiments, we have modified the shotgun ribozyme prototype by using a unique molecule with combined cis -and trans -acting ribozyme activity. In addition, we have designed a cloning procedure that allows the connection of a large number of these molecules into the tandem construct. The basic unit contains the sequence of a hammerhead ribozyme active in trans against the pre-genomic RNA of the hepatitis B virus. To make the molecule self-cleavable, we have included the target sequence recognized by the ribozyme downstream from the catalytic sequence. By cloning one unit after the other, each ribozyme is, in fact, surrounded by the target recognition sequence. This design allows the ribozyme to act in cis , cleaving the transcript and liberating itself with a minimum of extra sequences at 5 ′ and 3 ′ ends. There are two important aspects of this reaction that make it promising for further investigation: one is the fact that the self-processing of the transcripts occurs simultaneously with, or shortly after, the transcription reaction, as indicated by the presence of extensive cleavage of the transcripts immediately following the RNA synthesis; the second is the high efficiency of the self-cleaving process, even in the presence of target RNA, which might be expected to inhibit the process due to competition. This phenomenon is probably related to the folding of the multimeric transcript that favors selfhybridization and intramolecular cleavage. A similar observation showed the in vivo cleavage of a cis -ribozyme while the trans -acting counterpart, sharing the same target sequence, was not active (26) . The fact that the selfcleavage sequence is only 12-nt-long compared with the 24 nt present in the target RNA was not an impediment for the cis -reaction. The rationale for designing self-cleaving sequences was to generate short complementary ends that would not interfere with the transhybridizing reaction.
Comparison of the cleavage activities of monomers released from the multimeric ribozymes with that of two different (non-self-cleavable) ribozymes having different lengths of the 3 ′ tail of the molecule, Ribozymes II and III, showed that cleaved monomers were two to six times more effective in cleaving target RNA. This was true for either equal numbers of transcripts or when the number of pentameric Ribozyme I transcripts was corrected to compensate for the theoretical release of 5 monomers per transcript. Furthermore, Ribozyme I in equimolar amounts of total ribozyme units compared to target had the same efficiency of cleavage as a tenfold molar excess of the 3 ′ -truncated Ribozyme II, and was significantly (50%) more effective than a tenfold molar excess of the 3 ′ -extended Ribozyme III.
Also note that the observed significant cleavage rates were achieved despite low ribozyme-to-target ratios used in our experiments. Considering the fact that less than 80% of the pentameric ribozymes were self-cleaved into monomers during the digestion period, the actual ratios of monomer ribozyme to target were likely to be considerably less than the theoretical starting ratios of total ribozyme. This is in contrast to many reports of in vitro ribozyme activity in which molar ratios ranging from 50 to several hundred over target were required for activity. In addition, our target RNA was longer (858 nt) than targets commonly used, making more likely the formation of secondary structures that could hamper hybridization. This, therefore, represents a more challenging system to evaluate ribozyme cleavage efficiency. Finally, a pre-denaturing step was not used in the trans -cleavage reactions, in order to simulate activity of multimeric constructs under physiological conditions.
There are many reasons why the efficiency of producing monomeric ribozymes by self-cleavage of multimeric Ribozyme I is different from that described previously by others. In some of these experiments, the ribozymes were not multimeric (6,13) while in others, separate intercalated cisribozymes were used to generate monomers from a multimer (19) . Differences in folding of the multimeric molecules, changes in secondary structure of fragments after cleavage, affinity and release of fragments could contribute to differences in the results.
In conclusion, the simplicity of the cloning design allows for the construction of tandems containing large numbers of ribozyme units that self-cleave to form monomers that are short and highly active against their RNA targets. Although we have focused on multimeric ribozymes, all possessing the same target site in a message, it is also possible, using this same cloning strategy, to link multimeric ribozymes with different messenger target sites. The . Ribozyme III at a 1:1 ratio to target ( ) and at a 10:1 ratio to target ( w). Ribozyme I at a 0.2:1 ratio to target ( x); at a 1:1 ratio to target ( s); at a 2:1 ratio to target ( ); and at a 10:1 ratio to target ( v). B) Effect of preincubation on cleavage activity of Ribozyme I, which was incubated at 37°C for 3 h before the target was added. Pre-incubated ribozymes at 0.2:1( x); 2:1( q) and 10:1 ( v) molar ratios to target. Non-pre-incubated ribozymes at ratios of 0.2:1 ( ) , 2:1 ( O) and10:1( ∆ ) .
advantages of this system may prove useful in enhancing the potential of ribozymes for inhibition of intracellular gene expression. While the results demonstrate the possibility of generating self-cleavable multimeric ribozymes, they cannot be used to predict efficient self-cleavage in vivo.
